118 related articles for article (PubMed ID: 10716314)
1. Use of 99mTc-furifosmin scintigraphy--planar and SPECT--to evaluate suggestive palpable and nonpalpable breast lesions.
Obwegeser R; Berghammer P; Rodrigues M; Kubista E; Sinzinger H
J Nucl Med; 2000 Mar; 41(3):426-8. PubMed ID: 10716314
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas.
Spanu A; Schillaci O; Meloni GB; Porcu A; Cottu P; Nuvoli S; Falchi A; Chessa F; Solinas ME; Madeddu G
Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
4. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Brandt-Mainz K; Müller SP; Sonnenschein W; Bockisch A
J Nucl Med; 1998 Sep; 39(9):1536-41. PubMed ID: 9744338
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
7. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions.
Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H
Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790
[TBL] [Abstract][Full Text] [Related]
8. First experiences with technetium-99m furifosmin as tumour-seeking agent in breast cancer and recurrent ovarian cancer.
Aigner RM; Fueger GF
Eur J Nucl Med; 1997 Sep; 24(9):1167-70. PubMed ID: 9283112
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Aziz A; Hashmi R; Ogawa Y; Hayashi K
Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
Tiling R; Tatsch K; Sommer H; Meyer G; Pechmann M; Gebauer K; Münzing W; Linke R; Khalkhali I; Hahn K
J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588
[TBL] [Abstract][Full Text] [Related]
12. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin.
Naruse H; Daher E; Sinusas A; Jain D; Natale D; Mattera J; Makuch R; Wackers FJ
J Nucl Med; 1996 Nov; 37(11):1783-8. PubMed ID: 8917175
[TBL] [Abstract][Full Text] [Related]
14. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
15. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
16. Scintimammography and single-photon emission computed tomography for postoperative image guidance for radiation treatment planning in breast cancer patients.
Piperkova E; Chavdarova L; Garanina Z; Gocheva L; Parvanova V; Tzonevska A; Dimitrova M
J BUON; 2011; 16(4):657-63. PubMed ID: 22331718
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions.
Spanu A; Ginesu F; Pirina P; Solinas ME; Schillaci O; Farris A; Chessa F; Madeddu G; Marongiu P; Falchi A; Nuvoli S; Madeddu G
Int J Oncol; 2003 Mar; 22(3):639-49. PubMed ID: 12579319
[TBL] [Abstract][Full Text] [Related]
18. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in suspected recurrent breast cancer.
Yildiz A; Garipağaoğlu M; Güngör F; Boz A; Dalmaz G
Cancer Biother Radiopharm; 2001 Apr; 16(2):163-9. PubMed ID: 11385963
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
20. Characterization of focal bone lesions in the axial skeleton: performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.
Strobel K; Burger C; Seifert B; Husarik DB; Soyka JD; Hany TF
AJR Am J Roentgenol; 2007 May; 188(5):W467-74. PubMed ID: 17449746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
